Literature DB >> 30666944

Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas.

Gaurav Sharma, Vishnu Dutt Sharma.   

Abstract

Entities:  

Keywords:  Mycobacterium lepromatosis; United States; bacteria; host susceptibility; leprosy; travel-related hazard

Mesh:

Year:  2019        PMID: 30666944      PMCID: PMC6346460          DOI: 10.3201/eid2502.171895

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Virk et al. () reported a Mycobacterium lepromatosis infection in a US citizen with a history of multiple international travels and concluded that M. lepromatosis lepromatous leprosy is a travel-related hazard for travelers to endemic areas. The conclusions drawn, however, need extensive support of thoroughly conducted case studies before generalizing M. lepromatosis as a travel-related hazard. In the case report, the exact source of M. lepromatosis infection was unclear. Moreover, experimental evidence used in this work are not enough to prove that M. lepromatosis is a travel-related hazard. Confirming a source of infection by DNA fingerprinting of M. lepromatosis can be ideal to rule out infection from unreported native patients or environmental reservoirs (). It is possible that the patient in this report may have contracted M. lepromatosis infection as a result of his host-susceptible genetic factors. Host genetic susceptibility to leprosy is complicated because of the genetics of M. lepromatosis, interaction between genetic and environmental factors, gene–gene interactions, and ethnicity (). Host genetics plays a major role in determining a person’s risk of developing clinical leprosy. Thus, even a short trip to a leprosy-endemic country is sufficient for a host susceptible to M. lepromatosis to acquire an infection. The host immune response influences the course of leprosy infection; it is challenging to understand the genetics of disease susceptibility and immunopathogenesis of leprosy (,). With an inference of only a single case study, it is hard to say that M. lepromatosis lepromatous leprosy is a travel-related hazard for all US citizens. More surveillance data, such as patients’ immunity toward the disease, their genetic susceptibility, and travel history, are needed to explore the travel-related hazard. In addition, evolutionary knowledge and how widely the disease is circulating in nonendemic regions will help in understanding the nature of the disease.
  5 in total

1.  Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis.

Authors:  Pushpendra Singh; Andrej Benjak; Verena J Schuenemann; Alexander Herbig; Charlotte Avanzi; Philippe Busso; Kay Nieselt; Johannes Krause; Lucio Vera-Cabrera; Stewart T Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 2.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

3.  Unveiling healthy carriers and subclinical infections among household contacts of leprosy patients who play potential roles in the disease chain of transmission.

Authors:  Sérgio Araújo; Janaína Lobato; Erica de Melo Reis; Dulcinéa Oliveira Bernardes Souza; Maria Aparecida Gonçalves; Adeilson Vieira Costa; Luiz Ricardo Goulart; Isabela Maria Bernardes Goulart
Journal:  Mem Inst Oswaldo Cruz       Date:  2012-12       Impact factor: 2.743

Review 4.  Environmental nonhuman sources of leprosy.

Authors:  L A Blake; B C West; C H Lary; J R Todd
Journal:  Rev Infect Dis       Date:  1987 May-Jun

5.  Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas.

Authors:  Abinash Virk; Bobbi Pritt; Robin Patel; James R Uhl; Spencer A Bezalel; Lawrence E Gibson; Barbara M Stryjewska; Margot S Peters
Journal:  Emerg Infect Dis       Date:  2017-11       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.